313
Participants
Start Date
September 8, 2015
Primary Completion Date
November 18, 2019
Study Completion Date
November 18, 2019
Cabiralizumab
Solution for IV administration
Nivolumab
Solution for IV administration
Memorial Sloan Kettering, New York
Roswell Park Cancer Institute, Buffalo
University of Pittsburgh Cancer Institute, William M. Cooper Ambulatory Pavilion of the Hillman Cancer Center, Pittsburgh
Hospital of the University of Pennsylvania, Philadelphia
Thomas Jefferson University Hospital, Philadelphia
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Hollings Cancer Center, Medical University of South Carolina, Charleston
Emory University Hospital, Atlanta
Mount Sinai Comprehensive Cancer Center, Miami Beach
H. Lee Moffitt Cancer Center and Research Institute, Tampa
Henry-Joyce Cancer Clinic, Vanderbilt-Ingram Cancer Center,, Nashville
Norton Cancer Institute, Norton Healthcare Pavilion, Louisville
The Christ Hospital, Cincinnati
Indiana University Health Hospital, Indianapolis
Karmanos Cancer Institute, Detroit
Henry Ford Hospital, Detroit
University of Iowa Hospitals and Clinics, Iowa City
Allina Health, Virginia Piper Cancer Institute, Minneapolis
Rush University Medical Center, Chicago
University of Chicago Medical Center, Chicago
Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas
University of Texas Southwestern Medical Center, Dallas
Mischer Neuroscience Associates, The University of Texas Health Science Center at Houston, Houston
The University of Texas MD Anderson Cancer Center, Houston
Cancer Therapy & Research Center, University of Texas Health Science Center at San Antonio, San Antonio
South Texas Accelerated Research Therapeutics, LLC, San Antonio
Huntsman Cancer Institute, Salt Lake City
Scottsdale Healthcare Hospitals DBA Honor Health, Scottsdale
Norris Comprehensive Cancer Center, University of Southern California, Los Angeles
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Center, Los Angeles
Sarcoma Oncology Research Center, Santa Monica
UCLA Hematology/Oncology- Santa Monica, Santa Monica
Moores UC San Diego Cancer Center, La Jolla
University of California, San Francisco, San Francisco
UC Davis Comprehensive Cancer Center, Sacramento
Providence Portland Medical Center, Portland
Oregon Health and Science University, Portland
Seattle Cancer Care Alliance, Seattle
Dana Farber Cancer Institute, Boston
Lead Sponsor
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Five Prime Therapeutics, Inc.
INDUSTRY